This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurokohchi, K.
Right arrow Articles by Berzofsky, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurokohchi, K.
Right arrow Articles by Berzofsky, J. A.

 Previous Article  |  Next Article 

J. Virol., Jan 1996, 232-240, Vol 70, No. 1
Copyright © 1996, American Society for Microbiology

Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region

K Kurokohchi, T Akatsuka, CD Pendleton, A Takamizawa, M Nishioka, M Battegay, SM Feinstone and JA Berzofsky
Molecular Immunogenetics and Vaccine Research Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

To define cytotoxic T-cell (CTL) epitopes, the common approach involving the use of a series of overlapping synthetic peptides covering the whole protein sequence is impractical for large proteins. Motifs identify only a fraction of epitopes. To identify human CTL epitopes in the NS3 region of hepatitis C virus (HCV), we modified an approach using recombinant protein and the ability of short peptides to bind to class I major histocompatibility complex (MHC) molecules. Peripheral blood mononuclear cells from an HCV-infected patient were stimulated with a proteolytic digest of the recombinant NS3 protein to expand CTL to any active peptides in the digest. The digest was fractionated by reverse-phase high-performance liquid chromatography, and fractions were assessed for the ability to sensitize targets for lysis by CTL. The most active fraction was sequenced, identifying a 15- residue peptide (NS3-1J; TITTGAPVTYSTYGK). This sequence was confirmed to be the source of the activity by synthesis of the corresponding peptide. CTL lines specific for NS3-1J were established from two HCV- infected patients (both HLA-A2 and -B7 positive) by stimulation with the synthetic peptide in vitro. The CTL were HLA-A2 restricted, and the minimal epitope was mapped to a decapeptide NS3-1J (10.4). As this minimal epitope lacks the common HLA-A2-binding motif, this technique is useful for mapping CTL epitopes independent of known motifs and without the requirement for enormous numbers of overlapping peptides. Because this peptide is presented by the most common HLA class I molecule, present in almost half the population, it might be a useful component of a vaccine against HCV.


This article has been cited by other articles:

  • Doytchinova, I. A., Walshe, V. A., Jones, N. A., Gloster, S. E., Borrow, P., Flower, D. R. (2004). Coupling In Silico and In Vitro Analysis of Peptide-MHC Binding: A Bioinformatic Approach Enabling Prediction of Superbinding Peptides and Anchorless Epitopes. J. Immunol. 172: 7495-7502 [Abstract] [Full Text]  
  • Yu, H., Babiuk, L. A., van Drunen Littel-van den Hurk, S. (2004). Priming with CpG-enriched plasmid and boosting with protein formulated with CpG oligodeoxynucleotides and Quil A induces strong cellular and humoral immune responses to hepatitis C virus NS3. J. Gen. Virol. 85: 1533-1543 [Abstract] [Full Text]  
  • Huarte, E., Sarobe, P., Lu, J., Casares, N., Lasarte, J. J., Dotor, J., Ruiz, M., Prieto, J., Celis, E., Borras-Cuesta, F. (2002). Enhancing Immunogenicity of a CTL Epitope from Carcinoembryonic Antigen by Selective Amino Acid Replacements. Clin. Cancer Res. 8: 2336-2344 [Abstract] [Full Text]  
  • Mizukoshi, E., Nascimbeni, M., Blaustein, J. B., Mihalik, K., Rice, C. M., Liang, T. J., Feinstone, S. M., Rehermann, B. (2002). Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies. J. Virol. 76: 6093-6103 [Abstract] [Full Text]  
  • Lauer, G. M., Ouchi, K., Chung, R. T., Nguyen, T. N., Day, C. L., Purkis, D. R., Reiser, M., Kim, A. Y., Lucas, M., Klenerman, P., Walker, B. D. (2002). Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities. J. Virol. 76: 6104-6113 [Abstract] [Full Text]  
  • Brinster, C., Chen, M., Boucreux, D., Paranhos-Baccala, G., Liljestrom, P., Lemmonier, F., Inchauspe, G. (2002). Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles. J. Gen. Virol. 83: 369-381 [Abstract] [Full Text]  
  • Wong, D. K. H., Dudley, D. D., Dohrenwend, P. B., Lauer, G. M., Chung, R. T., Thomas, D. L., Walker, B. D. (2001). Detection of Diverse Hepatitis C Virus (HCV)-Specific Cytotoxic T Lymphocytes in Peripheral Blood of Infected Persons by Screening for Responses to All Translated Proteins of HCV. J. Virol. 75: 1229-1235 [Abstract] [Full Text]  
  • Major, M. E., Mihalik, K., Fernandez, J., Seidman, J., Kleiner, D., Kolykhalov, A. A., Rice, C. M., Feinstone, S. M. (1999). Long-Term Follow-Up of Chimpanzees Inoculated with the First Infectious Clone for Hepatitis C Virus. J. Virol. 73: 3317-3325 [Abstract] [Full Text]  
  • Wong, D. K. H., Dudley, D. D., Afdhal, N. H., Dienstag, J., Rice, C. M., Wang, L., Houghton, M., Walker, B. D., Koziel, M. J. (1998). Liver-Derived CTL in Hepatitis C Virus Infection: Breadth and Specificity of Responses in a Cohort of Persons with Chronic Infection. J. Immunol. 160: 1479-1488 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»